2009-11-03
(WASHINGTON) – The American Society of
Hematology, the world’s largest professional society of blood specialists,
welcomes five new officers to its Executive Committee, the governing body of
the organization. The officers will begin serving their terms in January 2010.
Armand Keating, MD, will serve a
one-year term as vice-president, followed by successive terms as president-elect
and president. New councillors Marilyn J. Telen, MD, and Kenneth C. Anderson,
MD, will serve four-year terms, and Mohandas Narla, DSc, will serve as
councillor for a one-year term. These individuals are well-respected
hematologists and active members of the Society.
Dr. Keating is Professor of Medicine and Director,
Division of Hematology, Epstein Chair in Cell Therapy and
Transplantation, University of Toronto, and Director, Cell Therapy
Program, Princess Margaret Hospital, Toronto. His clinical and research interests focus on
anti-cancer cell therapy, blood and marrow transplantation, leukemia, lymphoma,
and cell-based tissue regeneration. He has conducted laboratory, translational,
and clinical research in cell therapy, normal and leukemic hematopoiesis, and
the biology and clinical application of mesenchymal stromal cells.
Dr. Telen, Wellcome
Professor of Medicine and Chief, Division of Hematology, Duke University
Medical Center, is recognized as an expert in the biochemistry and molecular
genetics of blood group antigens and the pathophysiological mechanisms of
vaso-occlusion in sickle cell disease. She is the director of the Duke
Comprehensive Sickle Cell Center.
Dr. Anderson, Kraft Family
Professor of Medicine, Harvard Medical School, Dana-Farber Cancer Institute (DFCI), is Chief of the Division of
Hematologic Neoplasia, Director of the Lipper Myeloma Center and Lebow
Institute for Myeloma Therapeutics, and Vice Chair of the Joint Program in
Transfusion Medicine at DFCI. His area of research is novel biologically based
therapies for multiple myeloma.
Dr. Narla, Vice President
for Research, New York Blood Center, is the Director of the Lindsley F. Kimball
Research Institute and heads the Laboratory of Red Cell Physiology at New
York Blood Center. His primary research focus is the study of the structural
organization of blood cell membranes in health and disease and on
regulation of blood cell production.
Reporters who wish to arrange an interview may contact
Patrick C. Irelan, ASH Communications Assistant, at 202-776-0544 or
pirelan@hematology.org.
The American Society of Hematology (www.hematology.org) is the world’s largest
professional society concerned with the causes and treatment of blood
disorders. Its mission is to further the understanding, diagnosis, treatment,
and prevention of disorders affecting blood, bone marrow, and the immunologic,
hemostatic, and vascular systems, by promoting research, clinical care,
education, training, and advocacy in hematology. ASH provides Blood: The Vital Connection (www.bloodthevitalconnection.org),
a credible online resource addressing bleeding and clotting disorders, anemia,
and cancer. The official journal of ASH is Blood
(www.bloodjournal.org), the most cited peer-reviewed
publication in the field, which is available weekly in print and online.
back to top
